{
  "original_study": {
    "claim": {
      "hypotheses": [
        "Subsidizing ACTs increases access but may lead to over-treatment.",
        "Subsidies combined with diagnostic tests improve targeting of treatments."
      ],
      "hypotheses_location": "Not directly stated in the paper summary but implied in the methodology and results sections.",
      "statement": "Price Subsidies and diagnostic tests improve targeting and access to malaria treatments.",
      "statement_location": "Referenced throughout the methodology and results sections discussing the impact of subsidies on access and targeting.",
      "study_type": "Experimental"
    },
    "data": {
      "source": "Field experiment with household surveys in Western Kenya.",
      "wave_or_subset": "Data collected from May to December 2009.",
      "sample_size": "2,928 households",
      "unit_of_analysis": "Household",
      "access_details": "Not stated",
      "notes": "The study employed a randomized controlled trial with different subsidy levels and diagnostic test access."
    },
    "method": {
      "description": "The study used a randomized controlled trial to assess the impact of varying subsidy levels on malaria treatment access and targeting.",
      "steps": [
        "Randomly assign households to different subsidy and diagnostic test groups.",
        "Introduce variation in access to subsidized ACTs and RDTs.",
        "Track treatment-seeking behavior and medication consumption over time."
      ],
      "models": "Regression analysis",
      "outcome_variable": "ACT usage and targeting accuracy",
      "independent_variables": "Subsidy levels, access to diagnostic tests",
      "control_variables": "Household demographic characteristics, baseline malaria knowledge",
      "tools_software": "Not stated"
    },
    "results": {
      "summary": "High subsidies increased access to ACTs but also led to a significant portion being misallocated to patients without malaria. Targeting improved with lower subsidies, and diagnostic tests increased testing rates but did not substantially decrease over-treatment.",
      "numerical_results": [
        {
          "outcome_name": "Share of illnesses treated with ACTs",
          "value": "0.41",
          "unit": "proportion",
          "effect_size": "Not stated",
          "confidence_interval": {
            "lower": "Not stated",
            "upper": "Not stated",
            "level": "Not stated"
          },
          "p_value": "Not stated",
          "statistical_significance": "Not stated",
          "direction": "Positive"
        }
      ]
    },
    "metadata": {
      "original_paper_id": "Not stated",
      "original_paper_title": "Price Subsidies, Diagnostic Tests, and Targeting of Malaria Treatment: Evidence from a Randomized Controlled Trial",
      "original_paper_code": "Not stated",
      "original_paper_data": "Not stated"
    }
  }
}